美股市場個股詳情
ACER ACER THERAPEUTICS INC
- 0.660
- 0.0000.00%
延時15分鐘行情收盤價 08/13 16:00 (美東)
1614.85萬總市值-0.34市盈率TTM
0.000最高價0.000最低價0股成交量0.000今開0.660昨收0.00成交額0.00%換手率虧損市盈率(靜)2446.37萬總股本0.66052周最高-0.49市淨率1248.83萬流通值0.66052周最低--股息TTM1891.87萬流通股0.660歷史最高--股息率TTM0.00%振幅0.660歷史最低--平均價1股每手
關於ACER THERAPEUTICS INC公司
Acer Therapeutics Inc是一家制藥公司。 原則上，它專注於針對嚴重的稀有和超稀有疾病以及關鍵的未滿足醫療需求的患者的療法的獲取，開發和商業化。 該公司的臨牀項目包括三類嚴重的遺傳疾病，即針對vEDS的EDSIVO和針對尿素循環疾病和楓糖漿尿病的ACER-001。
公司介紹
董事高管
- 姓名
- 職務
- 年薪
- Chris Schelling
- Director, President and Chief Executive Officer
- 83.43萬
- John M. Klopp
- Chief Technical Officer
- --
- Harry S. Palmin
- Principal Accounting Officer and Chief Financial Officer
- 59.26萬
- Bernie Paul
- Chief People Officer
- --
- Donald R. Joseph
- Chief Legal Officer and Secretary
- --
- Dr. Adrian Quartel
- Chief Medical Officer
- 80.10萬
- Tanya Hayden
- Chief Operating Officer
- --
- Jefferson E. Davis
- Chief Business Officer
- --
- Stephen J. Aselage
- Chairman of the Board
- 10.50萬
- Jason Amello
- Independent Director
- 8.31萬
- Michelle R. Griffin
- Independent Director
- 8.81萬
- John M. Dunn
- Independent Director
- 8.50萬
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據